Latest news with #Imunon
Business Insider
3 days ago
- Business
- Business Insider
Imunon files to sell 22.03M shares of common stock for holders
17:04 EDT Imunon (IMNN) files to sell 22.03M shares of common stock for holders Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Yahoo
4 days ago
- Business
- Yahoo
Imunon, Inc. (IMNN) Raises $3.25M in Private Placement, Eyes $6.5M More
Imunon, Inc. (NASDAQ:IMNN) has completed a private placement, securing $3.25 million in initial funding by selling 7,222,223 shares of common stock or pre-funded warrants at $0.45 each. The deal also grants investors short-term warrants to buy up to 14,444,446 additional shares at the same price. If all warrants are exercised within three years after shareholder approval, Imunon, Inc. (NASDAQ:IMNN) could raise an extra $6.5 million, bringing total potential proceeds to $9.75 million. A technician using a pipette to mix a bright blue chemical solution in a laboratory. H.C. Wainwright & Co. led the transaction, with Brookline Capital Markets as co-placement agent. The funds are earmarked for working capital and general corporate needs. The securities, offered only to accredited investors under a private placement, are not registered with the SEC and cannot be resold publicly until registration is completed. Imunon, Inc. (NASDAQ:IMNN) has agreed to file registration statements for future resale, and this announcement does not represent an offer or sale where prohibited by law. IMNN has surged by nearly 45% since the start of 2025. While we acknowledge the potential of IMNN to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than IMNN and that has 100x upside potential, check out our report about this READ NEXT: and Disclosure: None. Sign in to access your portfolio
Yahoo
5 days ago
- Business
- Yahoo
Imunon, Inc. (IMNN) Raises $3.25M in Private Placement, Eyes $6.5M More
Imunon, Inc. (NASDAQ:IMNN) has completed a private placement, securing $3.25 million in initial funding by selling 7,222,223 shares of common stock or pre-funded warrants at $0.45 each. The deal also grants investors short-term warrants to buy up to 14,444,446 additional shares at the same price. If all warrants are exercised within three years after shareholder approval, Imunon, Inc. (NASDAQ:IMNN) could raise an extra $6.5 million, bringing total potential proceeds to $9.75 million. A technician using a pipette to mix a bright blue chemical solution in a laboratory. H.C. Wainwright & Co. led the transaction, with Brookline Capital Markets as co-placement agent. The funds are earmarked for working capital and general corporate needs. The securities, offered only to accredited investors under a private placement, are not registered with the SEC and cannot be resold publicly until registration is completed. Imunon, Inc. (NASDAQ:IMNN) has agreed to file registration statements for future resale, and this announcement does not represent an offer or sale where prohibited by law. IMNN has surged by nearly 45% since the start of 2025. While we acknowledge the potential of IMNN to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than IMNN and that has 100x upside potential, check out our report about this READ NEXT: and Disclosure: None.
Yahoo
7 days ago
- Business
- Yahoo
Imunon announces up to $9.75M private placement priced at-the-market
Imunon (IMNN) announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 7,222,223 shares of its common stock or pre-funded warrants in lieu therof and short-term warrants to purchase up to an aggregate of 14,444,446 shares of common stock at a purchase price of 45c per share or pre-funded warrant in lieu thereof and accompanying short-term warrants in a private placement priced at-the-market under Nasdaq rules. The warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares of common stock upon exercise of the warrants at an exercise price of 45c per share and will expire three years from the date of stockholder approval. The offering is expected to close on or about May 27, subject to the satisfaction of customary closing conditions. H.C. Wainwright is acting as the the exclusive placement agent for the offering. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on IMNN: Disclaimer & DisclosureReport an Issue Morning News Wrap-Up: Friday's Biggest Stock Market Stories! Imunon Stock (IMNN) Rockets on Clinical Trial Results Imunon announces data from Phase 2 OVATION 2 study on IMNN-001 Imunon announces withdrawal of Form S-1 Registration Statement Imunon Withdraws Registration Statement Impacting Strategy Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
23-05-2025
- Business
- Business Insider
Imunon announces withdrawal of Form S-1 Registration Statement
Imunon (IMNN) announced that it has filed a request for withdrawal with the SEC of the company's Registration Statement on Form S-1 (No. 333-286403), as amended, originally filed on April 4, 2025, as the company no longer intends to pursue a public offering under the Registration Statement at this time. The Registration Statement has not been declared effective by the SEC, and no securities have been sold in connection with the offering described in the Registration Statement. Confident Investing Starts Here:
